Displaying items by tag: release

Chemotherapy is a common treatment for TNBC, but studies show that only 40 percent of tumors respond to the treatment. A team of researchers have developed a model using machine learning to predict patient responses.
The BFA exhibition represents crossing the threshold into the professional environment for students who are often showing their work for the first time in the setting of a gallery or museum.
This research analyzes the oral health of geriatric and pediatric patients in Southeast Alaska.
Through a generous gift from Novo Nordisk Inc., Live HealthSmart Alabama is beginning to expand statewide, starting in central Alabama with Selma, Demopolis and Camden, while taking steps to make good health simple — one person, one family and one community at a time.
Participants between the ages of 18 and 60 who received peer coaching showed significant reduction in systolic blood pressure.
They have historic ties, but the co-production of “Sister Act” marks the beginning of a new era. UAB students, faculty and alumni make up two-thirds of the team uniting to present this show.
Isaac completed two clinical trials in four years for multiple myeloma and says they gave him his life back.
This annual showcase concert features soloists and ensembles, choirs, bands and pianists performing music from classical, gospel and jazz to world music, electronic and more.
Four Department of Art and Art History students were honored for their student work by the American Advertising Federation of Birmingham.
Clinical trial findings from the LATITUDE study show promise in long-acting HIV treatment for patients who have long struggled with daily HIV oral medications.
A large nationwide study found that Black individuals carrying a genetic mutation in the TTN gene were at an increased risk of adverse clinical outcomes.
Results showed that African American veterans with PTSD had a higher risk of rehospitalization than those without PTSD. However, white veterans with PTSD did not have a significantly higher risk of rehospitalization post-stroke.
In the mouse brain, two neural pathways were discovered: The first is active during motivation; the second is active only at the termination of motivation. In humans, these pathways could underlie motivational dysfunctions present in various psychiatric conditions.
The award recognizes those in the medical community who have made monumental contributions to cancer prevention, control research and practice.
The award is the highest honor given by the ACMG Foundation for Genetic and Genomic Medicine.
Pulsed-field ablation disrupts the cellular membranes of vein tissue, irreversibly preventing those membranes from conducting electricity. This protects the heart from the rapid impulses which can cause atrial fibrillation.
UAB researchers leverage data from the SPRINT trial to show that intensive control of blood pressure reduces troponin I levels and this decrease in troponin I levels is associated with reduced risk of cardiovascular disease.
Page 4 of 231